Ontosight® – Biweekly NewsletterJune 17th – June 30th, 2024 –Read More
Ontosight® Newsletter Issue 3
Partnering to unlock the true potential of cannabis in medical care
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering to unlock the potential of phytocannabinoids in designing medical therapies. ESCHBORN, Germany, Oct 25th, 2021 – Innoplexus, a global leader in AI-based drug discovery and development; and DrD, an innovative biotechnology company focused on phytocannabinoids, are partnering to accelerate the clinical development and market authorization of …
Partnering to unlock the true potential of cannabis in medical care Read More »
Partnering to make 100,000s COVID-19 publications searchable
Michelle Hoiseth, Chief Data Officer for Parexel and Dr. Gunjan Bhardwaj, CEO Innoplexus discuss the importance of access to the latest COVID-19 data. The new COVID-19 Clearinghouse developed in partnership renders hundreds of thousands of coronavirus-related content searchable for users, updated in real-time and accessible for free.
Machine learning as an indispensable tool for Biopharma
The cost of developing a new drug roughly doubles every nine years (inflation-adjusted) aka Eroom’s law. As the volume of data for drug discovery and development explodes, the ability of Pharma and medical practitioners to keep up and accelerate drug discovery becomes more challenging. In contrast, the software industry reaps the benefits of Moore’s law …
Machine learning as an indispensable tool for Biopharma Read More »
Precision medicine and the discovery of biomarkers
In medicine, a Biomarker is a biological indicator, which can mark a state of a biology and is measurable. A Biomarker or a combination of few biomarkers can establish the biological state of an individual helping us understand the exact disease state and potential treatments. As a simple example, biomarker for fever is high temperature. …
Precision medicine and the discovery of biomarkers Read More »
FDA supports AI for drug development
AI technologies are more widely used in the pharmaceutical industry today to enable for its extensive review of scientific and medical literature. Extensive data obtained through AI can support the discovery of potential biomarkers, accelerate drug development and identify repurposing opportunities.1 The FDA sees tremendous potential in technologies such as machine and deep learning in healthcare. …
How Artificial Intelligence is accelerating research to treat COVID-19
The World Health Organization announced a pandemic in April 2020. Artificial intelligence technologies have presented effective methods for accelerating research, monitoring spread of infection and to identify effective treatments to fight with the novel coronavirus. Here are the various ways in which artificial intelligence has proved to be effective during this pandemic. I. Monitoring the …
How Artificial Intelligence is accelerating research to treat COVID-19 Read More »
AI as an effective tool to combat the novel coronavirus pandemic
First discovered in December 2019 in China, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had spread worldwide. By April 2020 it was declared a pandemic by the World Health Organization (WHO). There is now a race to developing a vaccine to cure COVID-19 (coronavirus disease 2019). COVID-19, which has affected more than 7 Million …
AI as an effective tool to combat the novel coronavirus pandemic Read More »
Real-time, real-world data in modern clinical research
The pharmaceutical industry is facing a pivotal time in the evolution of clinical research and trials. Emerging technologies with unprecedented potential are improving trial efficiency, safety, and accuracy. Improved methods of data collection and handling are at the forefront of these developments, leading to better procedures and enhanced outcomes. Real-time data makes a huge difference. …
Real-time, real-world data in modern clinical research Read More »
